Top Markets
Coin of the day
Diagonal Bio AB (publ) Diagonal Bio AB (publ)

Diagonal Bio AB (publ)

DIABIO
Rank in Stocks #40964
Diagonal Bio AB is a Swedish biotechnology firm dedicated to advancing the... Diagonal Bio AB is a Swedish biotechnology firm dedicated to advancing the Panviral platform. This innovative technology is engineered to pinpoint and diagnose minute genetic fragments belonging to a range of pathogens, such as viruses, bacteria, and fungi. Established in 2020, the company's main operations are based in Lund, Sweden.
Share Price
$0.00143282
Last synced: 2025-04-14
Market Cap
$57.28K
Change (1 day)
0.03%
Change (1 year)
0.00%
Country
SE
Trade Diagonal Bio AB (publ) (DIABIO)

Category

P/B ratio for Diagonal Bio AB (publ) (DIABIO)
P/B ratio as of 2026 TTM: 0
According to Diagonal Bio AB (publ) latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Diagonal Bio AB (publ) from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE